Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty-six brokerages that are covering the stock, Ratings reports. Fifteen equities ...

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on ...

Edwards Lifesciences Corp. closed $22.48 below its 52-week high ($96.12), which the company reached on March 28th.

Edwards Lifesciences Corp. closed $22.58 below its 52-week high ($96.12), which the company reached on March 28th.

Bernstein analyst Lee Hambright raised the firm’s price target on Edwards Lifesciences (EW) to $74 from $72 and keeps a Market Perform rating ...

Edwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the company Institutions' substantial holdings in Edwards Lifesciences implies that they ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Edwards Lifesciences (EW – Research Report) on January 6 and set a price ...

BofA Securities has recently raised Edwards Lifesciences Corp (EW) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 11, 2024, Morgan Stanley had resumed ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...

BofA Securities has recently raised Edwards Lifesciences Corp (EW) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 11, 2024, Morgan Stanley had resumed ...

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take ...

Edward Lifesciences remains a "Hold" as it trades close to its intrinsic value, despite improved fundamentals and solid third ...